Continuous infusion of amphotericin B: Preliminary experience at Faculdade de Medicina da Fundação ABC

Sao Paulo Medical Journal

Volumn 123, Issue 5, 2005, Pages 219-222

  Uehara, Roberto Palermo ^a   Lara de Sá, Victor Hugo ^a   Kashimura, Érika Tae ^a   Prudente, Fernanda Vilas Boas ^a   Cardozo de Mello Tucunduva, Luciana Tomanick ^a   Gonçalves, Marina Sahade ^a   Tibana Samano, Eliana Sueco ^a   del Giglio, Auro ^a,b  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b NONE   (Brazil)

Author keywords

Amphotericin B; Fever; Hematology; Leukemia; Neutropenia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CYCLOSPORIN; DIPHENHYDRAMINE; FLUCONAZOLE; FOSCARNET; PARACETAMOL; PETHIDINE; STEROID;

ADULT; ARTICLE; BRAZIL; CANCER CHEMOTHERAPY; CHILL; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE FACILITY; HEMATOLOGIC MALIGNANCY; HOSPITAL CARE; HUMAN; HYPOKALEMIA; LIVER TOXICITY; MALE; NEPHROTOXICITY; NEUTROPENIA; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 30644479056     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/s1516-31802005000500004     Document Type: Article

References (8)

1. Bodey G, Bueltmann 13, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis. 1992; 11(2):99-109.
2. Donowitz GR, Maki DG. Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient - new views of an old problem. Hematology (Am Soc Hematol Educ Program). 2001:113-39.
3. Walsh TJ, Finberg RW, Arndt C. et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infections Diseases Mycoses Study Group. N Engl J Med. 1999:340(10):764-71.
4. Walsh TJ, Pappas P. Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346(4):225-34.
5. Eriksson U, Seifert B. Schaffner A. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ. 2001;322(7286):579-82.
6. Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N. Randormized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis. 1999;28(2):331-40.
7. Cagnoni PJ, Walsh TJ, Prendergast MM, et al. Pharmacoeconimic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. J Clin Oncel. 2000;18(12):2476-83.
8. Barrett JP, Vardulaki KA. Conlon C, et al. A systematic review of the antifungal effectiveness and tolerability of amphotericin. B formulations. Clin Ther. 2003;25(5):1295-320.